Evidence map›Paper›PMID 42245315›Full record

ArticleFrontiers in surgery2026

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma.

Jakub Halámek, Ivan Špička, Zdeněk Krška, Kristian Chrz

Abstract readCase Reports
In one paragraph

Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jakub Halámek1st Surgical Department, General University Hospital, Prague, Czechia.
Ivan Špička1st Medical Faculty, Charles University, Prague, Czechia.
Zdeněk Krška1st Surgical Department, General University Hospital, Prague, Czechia.
Kristian Chrz1st Surgical Department, General University Hospital, Prague, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple myeloma is a haematological malignancy based on pathological monoclonal proliferation of plasma cells, which usually occurs in the bone marrow. Known aspects of its symptomatology include anaemia, renal failure, hypercalcaemia, osteolytic bone lesions and potentially consequences of AL amyloidosis. Diagnostics is multimodal and relies on laboratory and imaging methods of conventional radiology and nuclear medicine. Treatment is then the domain of the haematologist-oncologist. One form of this disease is extramedullary plasmacytoma, i.e., a solitary or multiple focus of multiple myeloma, which is not anatomically associated with bone marrow. This case report focuses on a patient with an advanced form of extramedullary plasmacytoma, who underwent partial cytoreductive surgery as a therapeutic attempt after exhausting all lines of conventional treatment. Case presentation: A 67-year-old male patient with an advanced form of extramedullary plasmacytoma was referred by his attending haematologist to the 1st Department of Surgery of General University Hospital in Prague of his attending haematologist to assess the possibility of extirpation of EMP lesions, due to the exhaustion of systemic therapy options. The aim of considered intervention was one of the macroscopically manifested soft tissue lesions of extramedullary plasmacytoma, which appeared suitable for surgical removal. After comprehensive preoperative assessment the elective surgical cytoreduction of the large lesion of extramedullary plasmacytoma above the right scapula was successfully performed. From the surgeon's perspective, the postoperative course was quite favourable without periprocedural complications, which ultimately led to the complete healing of the surgical wound. Despite achieving the primary surgical goal and the ongoing systemic treatment, the underlying disease developed to the stage beyond all possible therapeutic options, which ultimately led to the death of the patient. Discussion: In conclusion, despite the overall result of this case, it can be said about this therapeutic attempt that, assuming careful consideration of indications within the framework of interdisciplinary cooperation, considering all eventualities, this may be a relatively undemanding and safe procedure that does not exceed the capabilities of a standard surgical facility, is reproducible and potentially available as an addition to conventional treatment of extramedullary plasmacytoma in highly specific cases.

Indexed as

case reportcytoreductive surgeryextramedullary plasmacytoma (EP)multiple myelomawound healing

Identifiers

PMID42245315
PMCPMC13230160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.